Nau Jeffrey 4/A
4/A · Oyster Point Pharma, Inc. · Filed Dec 6, 2022
Insider Transaction Report
Form 4/AAmended
Nau Jeffrey
DirectorPresident and CEO
Transactions
- Tax Payment
Common Stock
2022-12-01$11.20/sh−8,938$100,106→ 148,660 total
Holdings
- 1,000(indirect: See Footnote)
Common Stock
Footnotes (2)
- [F1]The transaction reported represents the withholding of shares by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the non-reportable vesting and settlement of restricted stock units (the "RSUs"). Such RSUs were previously reported on the Reporting Person's Form 4 as to (i) 25,898 filed with the Securities and Exchange Commission on February 2, 2021 (the "2021 Award"); and (ii) 46,700 filed with the Securities and Exchange Commission on January 11, 2022 (the "2022 Award"). 6,474 RSUs of the 2021 Award and 11,675 RSUs of the 2022 Award were subsequently accelerated, effective December 1, 2022, resulting in the withholding being reported herein.
- [F2]These shares are held by the Reporting Person's spouse.